How to Apply



The Clinical Genetics Residency program, accredited by the Residency Review Committee of the ACGME, is open to US citizens or permanent residents who have a U.S. or Canadian M.D. or D.O. degree and who have completed two years of residency in an ACGME-accredited program.




Foreign Medical Graduates


In some instances, an M.D. from abroad who has completed the equivalent of two or more years in an ACGME-accredited program may be substituted if approved by the American Board of Medical Genetics prior to enrolling in the Residency. These applicants will only be successful if they are US citizens or permanent residents, or bring their own stipend to the program. Outside funding is subject to approval by the University of Washington Graduate Medical Education Office, and must be confirmed prior to acceptance into the program.




Residency Application Process


We are members of the Electronic Residency Application Service (ERAS) and use the ERAS and National Resident Matching Program centralized application systems to review applications. ERAS opens in July, and applications should be completed by August 28th for timely consideration. On campus interviews are arranged between September and December on dedicated interview days. The campus interview last one or two days, and includes interviews with the Division Chief, the Program Director, and other faculty depending on availability and scheduling. Current clinical genetics residents and recent graduates of the program are available to meet with potential residents.

As an alternative, individual interviews may be arranged at the American Society of Human Genetics Meeting, which is generally scheduled in October or November. The program director reviews all applications to the program, being certain to identify qualifications that might make for success in our program:

  • Completeness of application, including a personal statement and official medical school transcript
  • Evidence of prior experience in Clinical or Human Genetics
  • Three letters of recommendation (one must be from your program director)
  • Research experience

Residency selection is based upon the total application and interviews. Given that our program is research-oriented, we are interested in applicants with demonstrated research interest. However, publications are not a requirement for an interview or acceptance into the program. A faculty committee determines the final ranking.




Questions


If you have questions, or need assistance, please contact
Sara Eisner, Program Administrator,
Medical Genetics Residency Program
seisner@uw.edu
Tel: (206) 543-4269





Training Programs




2013 Interview Dates for Residency Positions


The following dates for clinical genetics residency interviews have been scheduled:

  • Friday, August 23rd, 2013
  • Wednesday, October 16th, 2013
If you are invited for an interview, and are not available on either date, please contact Ms. Sara Eisner (contact information at the bottom of this page under Questions)) to make special arrangements for an alternative date. Applicants are expected to make their own travel arrangements, and we would be glad to provide suggestions.



Residency Application


Residency:  As of 2011, Medical Genetics uses ERAS and NRMP for those applying for the two-year categorical genetics training program. This year, ERAS will open in mid-July 2013: to ensure consideration of your application, please apply by August 28th, 2013. (Please only use the below applications for preliminary applications or after the match has closed). If you have any questions or need assistance, please contact Sara Eisner, Program Administrator - Medical Genetics Residency Program, seisner@uw.edu.


Residency Application in MS Word format
Residency Application in PDF format


Under-Represented Minority Recruitment


The University of Washington Medical Genetics Training Program has a strong historical commitment to recruitment of under-represented minorities. We encourage applicants from all minority physicians and scientists and will assign them the highest priority for review.